White House Condemns Iran Rocket Attack, Supports Israel Defense
(Bloomberg) -- The U.S. said it supports Israel's right to defend its citizens Thursday after Iran's "provocative" rocket attacks launched from Syria amid increased tensions following President Donald Trump's decision to quit the Iranian nuclear deal and impose broad sanctions.
In a statement, the White House said Iran's Islamic Revolutionary Guard Corps bears responsibility for "reckless actions" and called on that force as well as its proxies, including Hezbollah, to make no additional provocations.
Israel responded by conducting its biggest raid inside Syria in at least 30 years, saying Iranian forces there fired a barrage of missiles at the Israeli-held section of the Golan Heights.
"The United States condemns the Iranian regime's provocative rocket attacks from Syria against Israeli citizens, and we strongly support Israel's right to act in self-defense," White House Press Secretary Sarah Huckabee Sanders said in a statement. "The Iranian regime's deployment into Syria of offensive rocket and missile systems aimed at Israel is an unacceptable and highly dangerous development for the entire Middle East."
The statement also called on all nations to "make clear" that Iran's attack is a threat to international peace and stability. A showdown had seemed inevitable between the two Middle East powers. Israel has been warning against Iran's growing influence in Syria, and Iran had vowed to retaliate for deadly suspected Israeli air strikes last month on Iranian positions there.
To contact the reporter on this story: Terrence Dopp in Washington at tdopp@bloomberg.net.
To contact the editors responsible for this story: Derek Wallbank at dwallbank@bloomberg.net, Elizabeth Wasserman, Kathleen Hunter
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.